A study looking at finding pancreatic cancer early (UK-EDI)
Cancer type:
Status:
Phase:
This study is looking at different ways to try and find early signs of pancreatic cancer.
It is open to people who are at least 50 years old and have been recently diagnosed with type 2 diabetes.
Cancer Research UK supports this study.
More about this trial
For most people a diagnosis of 
is due to lifestyle or a fault in the . But for a small number of people a diagnosis of diabetes might be an early sign linked to developing pancreatic cancer. Researchers think this is around 1 in 100 people (1%). In this study the researchers call this type 3c diabetes.
It is important to know who has type 3c diabetes and who has type 2 diabetes. At the moment there are no tests or ways to find this out. By finding a way to tell the difference between type 2 and type 3c diabetes doctors might be able to detect the early signs of pancreatic cancer.
In this study researchers want to use blood samples and questionnaires to try and find a way to tell type 3c diabetes from type 2 diabetes.
The aims of this study are to:
- develop ways to tell type 3c diabetes from type 2 diabetes
- identify early signs of pancreatic cancer
Please note
You won’t get any benefit from taking part in this study. The researchers hope that the information gained from this study might help people in the future.
Who can enter
The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if you are at least 50 years old and have been diagnosed with diabetes within 6 months of joining the study.
Who can’t take part
You cannot join this study if any of these apply. You:
- have had a diagnosis of, or treatment for cancers linked to the pancreas such as bile duct cancer, pancreatic ductal adenocarcinoma (PDAC) or neuroendocrine tumours (NETs) of the pancreas
- had surgery to remove part of the pancreas
- are pregnant
Trial design
The team need 2,500 people to join the study.
You give blood samples and fill in questionnaires when you join the study and then every 6 months to 2 years.
Hospital visits
You see a member of the study team at a local clinic every 6 months for 2 years. The first visit takes about an hour all the others take about 30 minutes.
Side effects
There are no side effects if you take part in the study.
Location
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor Eithne Costell
Supported by
Cancer Research UK
University of Liverpool
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
Last reviewed:
Dangoor Education since 2010.
